Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β 2 -agonist dual therapy in a primary care setting in England.

MLA

Czira, Alexandrosz, et al. “Characterisation of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Device Inhaled Corticosteroids/Long-Acting β 2 -Agonist Dual Therapy in a Primary Care Setting in England.” BMJ Open Respiratory Research, vol. 9, no. 1, Sept. 2022. EBSCOhost, https://doi.org/10.1136/bmjresp-2022-001243.

APA

Czira, A., Banks, V., Requena, G., Wood, R., Tritton, T., Wild, R., Compton, C., Duarte, M., & Ismaila, A. S. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β 2 -agonist dual therapy in a primary care setting in England. BMJ Open Respiratory Research, 9(1). https://doi.org/10.1136/bmjresp-2022-001243

Chicago

Czira, Alexandrosz, Victoria Banks, Gema Requena, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton, Maria Duarte, and Afisi S Ismaila. 2022. “Characterisation of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Device Inhaled Corticosteroids/Long-Acting β 2 -Agonist Dual Therapy in a Primary Care Setting in England.” BMJ Open Respiratory Research 9 (1). doi:10.1136/bmjresp-2022-001243.